High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?

Backgroud COVID-19 coagulopathy linked to increased D-dimer levels has been associated with high mortality (Fei Z et al. in Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 395(10229):1054–62, 202...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thrombosis and thrombolysis 2021-02, Vol.51 (2), p.308-312
Hauptverfasser: Ibañez, C., Perdomo, J., Calvo, A., Ferrando, C., Reverter, J. C., Tassies, D., Blasi, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 312
container_issue 2
container_start_page 308
container_title Journal of thrombosis and thrombolysis
container_volume 51
creator Ibañez, C.
Perdomo, J.
Calvo, A.
Ferrando, C.
Reverter, J. C.
Tassies, D.
Blasi, A.
description Backgroud COVID-19 coagulopathy linked to increased D-dimer levels has been associated with high mortality (Fei Z et al. in Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 395(10229):1054–62, 2020). While D-dimer is accepted as a disseminated intravascular coagulation marker, rotational thromboelastometry (ROTEM) also detects fibrinolysis (Wright FL et al. in Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection. J Am Coll Surg (2020). Available from https://pubmed.ncbi.nlm.nih.gov/32422349/ [cited 14 Jun 2020]; Schmitt FCF et al. in Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care 9(1):19, 2019). We describe the ROTEM profile in severely ill COVID-19 patients and compare it with the standard laboratory coagulation test. Methods Adult patients diagnosed with COVID-19 admitted to the ICU were prospectively enrolled after Ethics Committee approval (HCB/2020/0371). All patients received venous thromboembolism prophylaxis; those on therapeutic anticoagulation were excluded. The standard laboratory coagulation test and ROTEM were performed simultaneously at 24–48 h after ICU admission. Sequential organ failure assessment (SOFA), disseminated intravascular coagulation (DIC) and sepsis-induced coagulopathy (SIC) scores were calculated at sample collection. Results Nineteen patients were included with median SOFA-score of 4 (2–6), DIC-score of 1 (0–3) and SIC-score of 1.8 (0.9). Median fibrinogen, D-dimer levels and platelet count were 6.2 (4.8–7.6 g/L), 1000 (600–4200 ng/ml) and 236 (136–364 10 9 /L), respectively. Clot firmness was above the normal range in the EXTEM and FIBTEM tests while clot lysis was decreased. There was no significant correlation between ROTEM or D-dimer parameters and the SOFA score. Conclusion In COVID-19 patients, the ROTEM pattern was characterized by a hypercoagulable state with decreased fibrinolytic capacity despite a paradoxical increase in D-dimer levels. We suggest that, in COVID-19 patients, the lungs could be the main source of D-dimer, while a systemic hypofibrinolytic state coexists. This hypothesis should be confirmed by future studies.
doi_str_mv 10.1007/s11239-020-02226-0
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7363162</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2489907276</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-27f6bc2107903bf4835692896094799c207a77ee14dc770920dd2454dbab48c63</originalsourceid><addsrcrecordid>eNp9kU9vVCEUxYnR2LH6BVwYEjdunl4uPBhc2Jip2iZNulHjjvB4vDc0b2CEN9Z-exmn1j8LF4TF_d3DORxCnjJ4yQDUq8IYct0AQj2IsoF7ZMFaxRsl8Mt9sgCNumk5tEfkUSlXAKA14ENyxFEqJkEviD0L45qe0j5sfC7Uxp5O6ZqOU-rsRIfQ5RDTdFNCoS7576HMNES6uvx8fso03do5-DiX1_R6beuk0DGFONIU99S89tmfPCYPBjsV_-T2Piaf3r_7uDprLi4_nK_eXjROKDE3qAbZOWSgNPBuEEveSo1LXV0KpbVDUFYp75nonVI1GfQ9ilb0ne3E0kl-TN4cdLe7buN7V31lO5ltDhubb0yywfw9iWFtxvTNKC45k1gFXtwK5PR158tsNqE4P002-rQrBgUKIaTEPfr8H_Qq7XKs8Sq1rJ-sUO0d4YFyOZWS_XBnhoHZN2gODZraoPnZoIG69OzPGHcrvyqrAD8ApY7i6PPvt_8j-wO8A6Tm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489907276</pqid></control><display><type>article</type><title>High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Ibañez, C. ; Perdomo, J. ; Calvo, A. ; Ferrando, C. ; Reverter, J. C. ; Tassies, D. ; Blasi, A.</creator><creatorcontrib>Ibañez, C. ; Perdomo, J. ; Calvo, A. ; Ferrando, C. ; Reverter, J. C. ; Tassies, D. ; Blasi, A.</creatorcontrib><description>Backgroud COVID-19 coagulopathy linked to increased D-dimer levels has been associated with high mortality (Fei Z et al. in Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 395(10229):1054–62, 2020). While D-dimer is accepted as a disseminated intravascular coagulation marker, rotational thromboelastometry (ROTEM) also detects fibrinolysis (Wright FL et al. in Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection. J Am Coll Surg (2020). Available from https://pubmed.ncbi.nlm.nih.gov/32422349/ [cited 14 Jun 2020]; Schmitt FCF et al. in Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care 9(1):19, 2019). We describe the ROTEM profile in severely ill COVID-19 patients and compare it with the standard laboratory coagulation test. Methods Adult patients diagnosed with COVID-19 admitted to the ICU were prospectively enrolled after Ethics Committee approval (HCB/2020/0371). All patients received venous thromboembolism prophylaxis; those on therapeutic anticoagulation were excluded. The standard laboratory coagulation test and ROTEM were performed simultaneously at 24–48 h after ICU admission. Sequential organ failure assessment (SOFA), disseminated intravascular coagulation (DIC) and sepsis-induced coagulopathy (SIC) scores were calculated at sample collection. Results Nineteen patients were included with median SOFA-score of 4 (2–6), DIC-score of 1 (0–3) and SIC-score of 1.8 (0.9). Median fibrinogen, D-dimer levels and platelet count were 6.2 (4.8–7.6 g/L), 1000 (600–4200 ng/ml) and 236 (136–364 10 9 /L), respectively. Clot firmness was above the normal range in the EXTEM and FIBTEM tests while clot lysis was decreased. There was no significant correlation between ROTEM or D-dimer parameters and the SOFA score. Conclusion In COVID-19 patients, the ROTEM pattern was characterized by a hypercoagulable state with decreased fibrinolytic capacity despite a paradoxical increase in D-dimer levels. We suggest that, in COVID-19 patients, the lungs could be the main source of D-dimer, while a systemic hypofibrinolytic state coexists. This hypothesis should be confirmed by future studies.</description><identifier>ISSN: 0929-5305</identifier><identifier>EISSN: 1573-742X</identifier><identifier>DOI: 10.1007/s11239-020-02226-0</identifier><identifier>PMID: 32671609</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Aged ; Anticoagulants - administration &amp; dosage ; Cardiology ; Coronaviruses ; COVID-19 ; COVID-19 - blood ; COVID-19 Drug Treatment ; Disseminated intravascular coagulation ; Female ; Fibrin ; Fibrin Fibrinogen Degradation Products - metabolism ; Fibrinogen ; Fibrinolysis ; Hematology ; Humans ; Laboratories ; Lysis ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Morbidity ; Mortality ; Prophylaxis ; Retrospective Studies ; Risk factors ; SARS-CoV-2 - metabolism ; Sepsis ; Septic shock ; Thrombelastography ; Thromboembolism ; Thromboembolism - blood ; Thromboembolism - drug therapy</subject><ispartof>Journal of thrombosis and thrombolysis, 2021-02, Vol.51 (2), p.308-312</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-27f6bc2107903bf4835692896094799c207a77ee14dc770920dd2454dbab48c63</citedby><cites>FETCH-LOGICAL-c474t-27f6bc2107903bf4835692896094799c207a77ee14dc770920dd2454dbab48c63</cites><orcidid>0000-0001-7186-9705</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11239-020-02226-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11239-020-02226-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,778,782,883,27907,27908,41471,42540,51302</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32671609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ibañez, C.</creatorcontrib><creatorcontrib>Perdomo, J.</creatorcontrib><creatorcontrib>Calvo, A.</creatorcontrib><creatorcontrib>Ferrando, C.</creatorcontrib><creatorcontrib>Reverter, J. C.</creatorcontrib><creatorcontrib>Tassies, D.</creatorcontrib><creatorcontrib>Blasi, A.</creatorcontrib><title>High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?</title><title>Journal of thrombosis and thrombolysis</title><addtitle>J Thromb Thrombolysis</addtitle><addtitle>J Thromb Thrombolysis</addtitle><description>Backgroud COVID-19 coagulopathy linked to increased D-dimer levels has been associated with high mortality (Fei Z et al. in Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 395(10229):1054–62, 2020). While D-dimer is accepted as a disseminated intravascular coagulation marker, rotational thromboelastometry (ROTEM) also detects fibrinolysis (Wright FL et al. in Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection. J Am Coll Surg (2020). Available from https://pubmed.ncbi.nlm.nih.gov/32422349/ [cited 14 Jun 2020]; Schmitt FCF et al. in Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care 9(1):19, 2019). We describe the ROTEM profile in severely ill COVID-19 patients and compare it with the standard laboratory coagulation test. Methods Adult patients diagnosed with COVID-19 admitted to the ICU were prospectively enrolled after Ethics Committee approval (HCB/2020/0371). All patients received venous thromboembolism prophylaxis; those on therapeutic anticoagulation were excluded. The standard laboratory coagulation test and ROTEM were performed simultaneously at 24–48 h after ICU admission. Sequential organ failure assessment (SOFA), disseminated intravascular coagulation (DIC) and sepsis-induced coagulopathy (SIC) scores were calculated at sample collection. Results Nineteen patients were included with median SOFA-score of 4 (2–6), DIC-score of 1 (0–3) and SIC-score of 1.8 (0.9). Median fibrinogen, D-dimer levels and platelet count were 6.2 (4.8–7.6 g/L), 1000 (600–4200 ng/ml) and 236 (136–364 10 9 /L), respectively. Clot firmness was above the normal range in the EXTEM and FIBTEM tests while clot lysis was decreased. There was no significant correlation between ROTEM or D-dimer parameters and the SOFA score. Conclusion In COVID-19 patients, the ROTEM pattern was characterized by a hypercoagulable state with decreased fibrinolytic capacity despite a paradoxical increase in D-dimer levels. We suggest that, in COVID-19 patients, the lungs could be the main source of D-dimer, while a systemic hypofibrinolytic state coexists. This hypothesis should be confirmed by future studies.</description><subject>Aged</subject><subject>Anticoagulants - administration &amp; dosage</subject><subject>Cardiology</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - blood</subject><subject>COVID-19 Drug Treatment</subject><subject>Disseminated intravascular coagulation</subject><subject>Female</subject><subject>Fibrin</subject><subject>Fibrin Fibrinogen Degradation Products - metabolism</subject><subject>Fibrinogen</subject><subject>Fibrinolysis</subject><subject>Hematology</subject><subject>Humans</subject><subject>Laboratories</subject><subject>Lysis</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Prophylaxis</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>SARS-CoV-2 - metabolism</subject><subject>Sepsis</subject><subject>Septic shock</subject><subject>Thrombelastography</subject><subject>Thromboembolism</subject><subject>Thromboembolism - blood</subject><subject>Thromboembolism - drug therapy</subject><issn>0929-5305</issn><issn>1573-742X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kU9vVCEUxYnR2LH6BVwYEjdunl4uPBhc2Jip2iZNulHjjvB4vDc0b2CEN9Z-exmn1j8LF4TF_d3DORxCnjJ4yQDUq8IYct0AQj2IsoF7ZMFaxRsl8Mt9sgCNumk5tEfkUSlXAKA14ENyxFEqJkEviD0L45qe0j5sfC7Uxp5O6ZqOU-rsRIfQ5RDTdFNCoS7576HMNES6uvx8fso03do5-DiX1_R6beuk0DGFONIU99S89tmfPCYPBjsV_-T2Piaf3r_7uDprLi4_nK_eXjROKDE3qAbZOWSgNPBuEEveSo1LXV0KpbVDUFYp75nonVI1GfQ9ilb0ne3E0kl-TN4cdLe7buN7V31lO5ltDhubb0yywfw9iWFtxvTNKC45k1gFXtwK5PR158tsNqE4P002-rQrBgUKIaTEPfr8H_Qq7XKs8Sq1rJ-sUO0d4YFyOZWS_XBnhoHZN2gODZraoPnZoIG69OzPGHcrvyqrAD8ApY7i6PPvt_8j-wO8A6Tm</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Ibañez, C.</creator><creator>Perdomo, J.</creator><creator>Calvo, A.</creator><creator>Ferrando, C.</creator><creator>Reverter, J. C.</creator><creator>Tassies, D.</creator><creator>Blasi, A.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7186-9705</orcidid></search><sort><creationdate>20210201</creationdate><title>High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?</title><author>Ibañez, C. ; Perdomo, J. ; Calvo, A. ; Ferrando, C. ; Reverter, J. C. ; Tassies, D. ; Blasi, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-27f6bc2107903bf4835692896094799c207a77ee14dc770920dd2454dbab48c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Anticoagulants - administration &amp; dosage</topic><topic>Cardiology</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - blood</topic><topic>COVID-19 Drug Treatment</topic><topic>Disseminated intravascular coagulation</topic><topic>Female</topic><topic>Fibrin</topic><topic>Fibrin Fibrinogen Degradation Products - metabolism</topic><topic>Fibrinogen</topic><topic>Fibrinolysis</topic><topic>Hematology</topic><topic>Humans</topic><topic>Laboratories</topic><topic>Lysis</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Prophylaxis</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>SARS-CoV-2 - metabolism</topic><topic>Sepsis</topic><topic>Septic shock</topic><topic>Thrombelastography</topic><topic>Thromboembolism</topic><topic>Thromboembolism - blood</topic><topic>Thromboembolism - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ibañez, C.</creatorcontrib><creatorcontrib>Perdomo, J.</creatorcontrib><creatorcontrib>Calvo, A.</creatorcontrib><creatorcontrib>Ferrando, C.</creatorcontrib><creatorcontrib>Reverter, J. C.</creatorcontrib><creatorcontrib>Tassies, D.</creatorcontrib><creatorcontrib>Blasi, A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of thrombosis and thrombolysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ibañez, C.</au><au>Perdomo, J.</au><au>Calvo, A.</au><au>Ferrando, C.</au><au>Reverter, J. C.</au><au>Tassies, D.</au><au>Blasi, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?</atitle><jtitle>Journal of thrombosis and thrombolysis</jtitle><stitle>J Thromb Thrombolysis</stitle><addtitle>J Thromb Thrombolysis</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>51</volume><issue>2</issue><spage>308</spage><epage>312</epage><pages>308-312</pages><issn>0929-5305</issn><eissn>1573-742X</eissn><abstract>Backgroud COVID-19 coagulopathy linked to increased D-dimer levels has been associated with high mortality (Fei Z et al. in Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 395(10229):1054–62, 2020). While D-dimer is accepted as a disseminated intravascular coagulation marker, rotational thromboelastometry (ROTEM) also detects fibrinolysis (Wright FL et al. in Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection. J Am Coll Surg (2020). Available from https://pubmed.ncbi.nlm.nih.gov/32422349/ [cited 14 Jun 2020]; Schmitt FCF et al. in Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care 9(1):19, 2019). We describe the ROTEM profile in severely ill COVID-19 patients and compare it with the standard laboratory coagulation test. Methods Adult patients diagnosed with COVID-19 admitted to the ICU were prospectively enrolled after Ethics Committee approval (HCB/2020/0371). All patients received venous thromboembolism prophylaxis; those on therapeutic anticoagulation were excluded. The standard laboratory coagulation test and ROTEM were performed simultaneously at 24–48 h after ICU admission. Sequential organ failure assessment (SOFA), disseminated intravascular coagulation (DIC) and sepsis-induced coagulopathy (SIC) scores were calculated at sample collection. Results Nineteen patients were included with median SOFA-score of 4 (2–6), DIC-score of 1 (0–3) and SIC-score of 1.8 (0.9). Median fibrinogen, D-dimer levels and platelet count were 6.2 (4.8–7.6 g/L), 1000 (600–4200 ng/ml) and 236 (136–364 10 9 /L), respectively. Clot firmness was above the normal range in the EXTEM and FIBTEM tests while clot lysis was decreased. There was no significant correlation between ROTEM or D-dimer parameters and the SOFA score. Conclusion In COVID-19 patients, the ROTEM pattern was characterized by a hypercoagulable state with decreased fibrinolytic capacity despite a paradoxical increase in D-dimer levels. We suggest that, in COVID-19 patients, the lungs could be the main source of D-dimer, while a systemic hypofibrinolytic state coexists. This hypothesis should be confirmed by future studies.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32671609</pmid><doi>10.1007/s11239-020-02226-0</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-7186-9705</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0929-5305
ispartof Journal of thrombosis and thrombolysis, 2021-02, Vol.51 (2), p.308-312
issn 0929-5305
1573-742X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7363162
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Aged
Anticoagulants - administration & dosage
Cardiology
Coronaviruses
COVID-19
COVID-19 - blood
COVID-19 Drug Treatment
Disseminated intravascular coagulation
Female
Fibrin
Fibrin Fibrinogen Degradation Products - metabolism
Fibrinogen
Fibrinolysis
Hematology
Humans
Laboratories
Lysis
Male
Medicine
Medicine & Public Health
Middle Aged
Morbidity
Mortality
Prophylaxis
Retrospective Studies
Risk factors
SARS-CoV-2 - metabolism
Sepsis
Septic shock
Thrombelastography
Thromboembolism
Thromboembolism - blood
Thromboembolism - drug therapy
title High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T18%3A48%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20D%20dimers%20and%20low%20global%20fibrinolysis%20coexist%20in%20COVID19%20patients:%20what%20is%20going%20on%20in%20there?&rft.jtitle=Journal%20of%20thrombosis%20and%20thrombolysis&rft.au=Iba%C3%B1ez,%20C.&rft.date=2021-02-01&rft.volume=51&rft.issue=2&rft.spage=308&rft.epage=312&rft.pages=308-312&rft.issn=0929-5305&rft.eissn=1573-742X&rft_id=info:doi/10.1007/s11239-020-02226-0&rft_dat=%3Cproquest_pubme%3E2489907276%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2489907276&rft_id=info:pmid/32671609&rfr_iscdi=true